[PMC free article: PMC8962946] [PubMed: 35360059] 59
Rarely but importantly, gallbladder and biliary diseases have been reported in clinical trials with GLP-1RAs (34)
Haluzkov D, Lacinov Z, Kavlkov P, Drpalov J, Kov J, Brtlov M, et al
Patients seeking significant weight reduction should explore other options, including peptides for weight loss or GLP-1 receptor agonists like tirzepatide
La decisin de iniciar un plan GLP-1 debe individualizarse considerando mltiples factores: objetivos glucmicos y ponderales del paciente, comorbilidades existentes, otros medicamentos actuales, preferencias del paciente respecto a la va de administracin, costo y cobertura de seguro
Provided herein are methods comprising the administration of said auris formulations or compositions on or near the round window membrane via intratympanic injection